Oracle beat earnings estimates in fiscal Q1 2027 with EPS of $1.92 and revenue of $19.345 billion, driven by strong cloud growth. Despite this, the stock is down 37.75% year to date, trading below key moving averages, as concerns over high capital spending, negative free cash flow, and rising debt weigh on investor sentiment. Analysts remain mostly bullish with a consensus price target implying nearly 97% upside, but the lone bear highlights risks from cash flow deficits and debt load. The next earnings report on December 14, 2026, will be closely watched for updates on free cash flow and capital spending plans.
As of Nov 10, 2026 21:21 WIB, Oracle shares trade at USD 118.27 on Pluang, down 1.27% for the day with a market cap of $373.47 billion. Despite the stock's year-to-date decline, Pluang investors show a majority buy interest at 67%, while the typical hold time is 76 days. The stock's dividend yield stands at 1.67%, reflecting ongoing income for shareholders amid mixed sentiment.
Wall Street analysts remain cautious on Super Micro Computer (SMCI), maintaining a 'Sell' rating and lowering its 12-month price target to $18, reflecting concerns despite the company's recovery from a 2024 accounting scandal. In contrast, Oracle (OR...
Oracle introduced two new AI-driven analytics applications—Financial Services Data Intelligence Treasury Analytics and Customer Analytics—to help financial institutions and insurers analyze complex data and make faster, informed decisions. These tool...
CoreWeave, OpenAI, and Oracle are encountering significant challenges amid a weakening AI market narrative and shifting investor sentiment. CoreWeave's credit risk has surged, with bond yields over 16% and CDS spreads at 1,240 basis points, indicatin...
Oracle revealed that its AI data centers generate modest returns, confirming expectations about the profitability of bare-metal compute. Despite market skepticism reflected in a low forward P/E of 14x and concerns over heavy AI capital expenditures a...
Oracle's cloud infrastructure revenue jumped 121% year-over-year, but rising capital expenditures and negative free cash flow have raised concerns about funding and leverage. The stock has dropped 54% from its high and currently trades below the anal...
